Literature DB >> 15788393

Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts.

Uzma A Hasan1, Giorgio Trinchieri, Jaromir Vlach.   

Abstract

Toll-like receptors (TLRs) are proteins involved in recognition of foreign pathogen-associated molecular patterns and activation of processes leading to innate immune recognition. We show that stimulation of fibroblasts with a TLR5 ligand, flagellin, can induce proliferation of serum-starved cells or prevent cell cycle exit upon serum withdrawal independently of autologous growth factor secretion. Other TLR ligands, such as poly(I:C) and lipopolysaccharide, can have a similar effect only if the action of type I interferons is blocked. Flagellin stimulation can prevent cell cycle arrest induced by overexpression of exogenous cyclin-dependent kinase inhibitor p27. Stimulation of TLR5 and overexpression of MyD88, but not TRIF, TIRAP, or TRAM, result in p27 degradation, which can be suppressed by dominant negative Akt and mutation of the p27 C-terminal Thr(187) site. These data provide evidence for a nonimmune and cell autonomous role of TLR signaling, whereby TLR stimulation provides a positive signal for cell division.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788393     DOI: 10.1074/jbc.M500877200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth.

Authors:  Zhenyu Cai; Amir Sanchez; Zhongcheng Shi; Tingting Zhang; Mingyao Liu; Dekai Zhang
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

Review 2.  Infectious disease, the innate immune response, and fibrosis.

Authors:  Alessia Meneghin; Cory M Hogaboam
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 3.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

4.  Innate adjuvant receptor Toll-like receptor 3 can promote breast cancer through cell surface.

Authors:  Banashree Bondhopadhyay; Anuradha Moirangthem; Anupam Basu
Journal:  Tumour Biol       Date:  2014-10-28

5.  Flagellin suppresses epithelial apoptosis and limits disease during enteric infection.

Authors:  Matam Vijay-Kumar; Huixia Wu; Rheinallt Jones; George Grant; Brian Babbin; Timothy P King; Denise Kelly; Andrew T Gewirtz; Andrew S Neish
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

6.  Glycosylation of Candida albicans cell wall proteins is critical for induction of innate immune responses and apoptosis of epithelial cells.

Authors:  Jeanette Wagener; Günther Weindl; Piet W J de Groot; Albert D de Boer; Susanne Kaesler; Selvam Thavaraj; Oliver Bader; Daniela Mailänder-Sanchez; Claudia Borelli; Michael Weig; Tilo Biedermann; Julian R Naglik; Hans Christian Korting; Martin Schaller
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 7.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

8.  Salmonella-induced SipB-independent cell death requires Toll-like receptor-4 signalling via the adapter proteins Tram and Trif.

Authors:  Pamela Cook; Sabine Tötemeyer; Catherine Stevenson; Katherine A Fitzgerald; Masahiro Yamamoto; Shizuo Akira; Duncan J Maskell; Clare E Bryant
Journal:  Immunology       Date:  2007-05-09       Impact factor: 7.397

9.  Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells.

Authors:  Sungsook Yu; Hyun Hwa Cho; Hye Joon Joo; Yong Chan Bae; Jin Sup Jung
Journal:  Mol Cell Biochem       Date:  2008-06-26       Impact factor: 3.396

10.  The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury.

Authors:  Jaklien C Leemans; Loes M Butter; Wilco P C Pulskens; Gwendoline J D Teske; Nike Claessen; Tom van der Poll; Sandrine Florquin
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.